Showing results (111-120 of 150) with videos related to
Sort By:
Pageof 15
Human Molecular Genetics|September 30, 2006
Secretin receptor-deficient mice exhibit impaired synaptic plasticity and social behaviorIchiko Nishijima, Takanori Yamagata, Corinne M Spencer, et al.The Journal of Molecular Diagnostics : JMD|June 10, 2021
Simultaneous Screening of the FRAXA and FRAXE Loci for Rapid Detection of FMR1 CGG and/or AFF2 CCG Repeat Expansions by Triplet-Primed PCRTiming Liu, Furene S Wang, Felicia S H Cheah, et al.Bioorganic & Medicinal Chemistry Letters|April 28, 2004
Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 4Vincent P Rocco, Patrick G Spinazze, Todd J Kohn, et al.Carcinogenesis|May 24, 2017
FXR-Gankyrin axis is involved in development of pediatric liver cancerLeila Valanejad, Kyle Lewis, Mary Wright, et al.Pathology, Research and Practice|September 29, 2012
Hyaluronan turnover and hypoxic brown adipocytic differentiation are co-localized with ossification in calcified human aortic valvesElizabeth H Stephens, Jerome G Saltarrelli, Liezl R Balaoing, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 30, 2002
Impaired conditioned fear and enhanced long-term potentiation in Fmr2 knock-out miceYanghong Gu, Kellie L McIlwain, Edwin J Weeber, et al.Blood|March 18, 2004
Altered leukocyte response to CXCL12 in patients with warts hypogammaglobulinemia, infections, myelokathexis (WHIM) syndromeAnna Virginia Gulino, Daniele Moratto, Silvano Sozzani, et al.Journal of Pathology Informatics|May 21, 2014
Autoverification in a core clinical chemistry laboratory at an academic medical centerMatthew D Krasowski, Scott R Davis, Denny Drees, et al.Bioorganic & Medicinal Chemistry Letters|December 20, 2003
Substituted furo[3,2-b]pyridines: novel bioisosteres of 5-HT 1F receptor agonistsBrian M Mathes, Kevin J Hudziak, John M Schaus, et al.Bioorganic & Medicinal Chemistry Letters|May 17, 2003
Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 1Kumiko Takeuchi, Todd J Kohn, Nicholas A Honigschmidt, et al.Pageof 15